China Junshi’s potential COVID drug shows promise in small trial
The drug, called VV116, is a derivative of Gilead Sciences's COVID drug Remdesivir and was approved for use in moderate-to-severe…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.